Last updated on May 2017

Yervoy Pregnancy Surveillance Study


Brief description of study

The study is a global safety surveillance study of pregnancy outcomes in women who were exposed to ipilimumab during pregnancy and pediatric outcomes up to 5 years of age

Clinical Study Identifier: NCT02854488

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Amy Miller, Site 0001

UBC
Morgantown, WV United States
  Connect »